|Bid||3.790 x 1000|
|Ask||25.000 x 2200|
|Day's Range||3.790 - 4.060|
|52 Week Range||3.100 - 9.310|
|PE Ratio (TTM)||-1.91|
|Forward Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Pain Therapeutics Inc (NASDAQ:PTIE), a USD$26.78M small-cap, operates in the healthcare industry, which continues to endure a more demanding healthcare agenda, and the global need for innovative, cost-effective medicines continuesRead More...
If you are a shareholder in Pain Therapeutics Inc’s (NASDAQ:PTIE), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...
On a per-share basis, the Austin, Texas-based company said it had a loss of 64 cents. The company's shares closed at $3.38. A year ago, they were trading at $18.23. _____ This story was generated by Automated ...
The Austin, Texas-based company said it had a loss of 6 cents per share. In the final minutes of trading on Tuesday, the company's shares hit 80 cents. A year ago, they were trading at $2.55. _____ This ...
Following the positive update, Pain Therapeutics stock spiked by around 61% to hit $1.10 per share during after hours trading on Monday.
Pain Therapeutics, Inc. (NASDAQ:PTIE) put out a fourth-quarter business update, and alongside it, gave us some insight into the possible future of the company’s long suffering abuse deterrent asset, Remoxy. This is one that we have covered in the past on a number of occasions here Market Exclusive, yet one that remains on an as-yet […]
The Austin, Texas-based company said it had a loss of 6 cents per share. For the year, the company reported a loss of $14.9 million, or 33 cents per share, swinging to a loss in the period. The company's ...
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
By Grant Zeng, CFA NASDAQ:DRRX Durect Exited Third Quarter with Strong Balance Sheet On October 31, Durect (NASDAQ:DRRX) announced its financial results for the third quarter of 2016 ended September 30. ...